These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3958706)

  • 1. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
    Svensson K; Carlsson A; Johansson AM; Arvidsson LE; Nilsson JL
    J Neural Transm; 1986; 65(1):29-38. PubMed ID: 3958706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
    Svensson K; Hjorth S; Clark D; Carlsson A; Wikström H; Andersson B; Sanchez D; Johansson AM; Arvidsson LE; Hacksell U
    J Neural Transm; 1986; 65(1):1-27. PubMed ID: 3083041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.
    Piercey MF; Lum JT
    Eur J Pharmacol; 1990 Jul; 182(2):219-26. PubMed ID: 2397740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.
    Svensson K; Carlsson M; Carlsson A; Hjorth S; Johansson AM; Eriksson E
    Eur J Pharmacol; 1986 Nov; 130(3):237-42. PubMed ID: 3792447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat.
    Svensson K; Alföldi P; Hajós M; Rubicsek G; Johansson AM; Carlsson A; Obál F
    Pharmacol Biochem Behav; 1987 Jan; 26(1):123-9. PubMed ID: 3562484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
    J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
    Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
    J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B; De Vries JB; Dijkstra D; Mulder TB; Horn AS
    Eur J Pharmacol; 1985 Feb; 109(2):229-40. PubMed ID: 3922776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion.
    Hajos M; Hjorth S; Svensson K; Carlsson A
    Exp Brain Res; 1988; 70(3):577-84. PubMed ID: 3133239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis.
    Timmerman W; Tepper PG; Dijkstra D; Stoelwinder H; Grol CJ; Westerink BH; Horn AS
    Eur J Pharmacol; 1991 Jun; 199(2):145-51. PubMed ID: 1683287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
    Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
    Piercey MF; Lum JT; Hoffmann WE; Carlsson A; Ljung E; Svensson K
    Brain Res; 1992 Aug; 588(2):217-22. PubMed ID: 1393576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Mulder TB; de Vries JB; Dijkstra D; Wiechers JW; Grol CJ; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):494-501. PubMed ID: 2830544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.